Investigators based at Monash Children's Hospital and Royal Children's Hospital Melbourne report that a once-daily intranasal ...
A new Australian study has found that a simple saline nasal spray could help many children breathe and sleep better, ...
Vivos Therapeutics, Inc. has announced the publication of positive results from a multicenter clinical trial on its Daytime-Nighttime Appliance (DNA) for treating obstructive sleep apnea (OSA) in ...
Vitamin D deficiency is common in children with severe obstructive sleep apnea (OSA) and is associated with increased OSA severity. Lower serum 25-hydroxyvitamin D levels correlate with higher ...
BUFFALO, N.Y. — Individuals diagnosed with obstructive sleep apnea, which causes the upper airway to become blocked during sleep, often rely on a continuous positive airway pressure (CPAP) machine ...
On Wednesday, the FDA granted 510(k) clearance to Vivos Therapeutics, Inc.’s (NASDAQ:VVOS) flagship oral medical device, which is used to treat moderate to severe obstructive sleep apnea (OSA) and ...
Sleep assessments in young children showed that, in the context of habitual snoring and enlarged tonsils and adenoids, moderate to severe obstructive sleep apnea increased the likelihood and magnitude ...
Kids with obstructive sleep apnea are often tired by day, have trouble paying attention, and have other behavioral problems all because they are not getting enough quality sleep at night. A new study ...
Over half of newborns with severe spina bifida experience sleep-disordered breathing, an often overlooked early threat to ...
The clinical syndrome of obstructive sleep apnea (OSAS) in children is a distinct, yet somewhat overlapping disorder with the condition that occurs in adults, such that the clinical manifestations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results